Neuronal pentraxin II (NPTX2) has been also verified using quantitative real-time polymerase chain reaction in an independent set of tumor specimens from rectal cancer patients, and it has been found that decreased NPTX2 gene expression levels are associated with improved response to nCRT and prognosis [105,116]. This evidence concerns the gene NPTX2 and rectal cancer.